Science ❯ Medicine

Pharmacology

Drug Development Drug Efficacy Hormones Opioids Obesity Treatment GLP-1 Receptor Agonists Cannabis Safety Studies Birth Control Pills Hormonal Contraceptives Anesthetic Drugs Endocrinology Drug Research Medications Indian Pharmacology Hormonal Therapies Biologics Vaccinology Antibiotics A3 Adenosine Receptor Agonists Drug Efficacy and Side Effects Hormonal Treatments GLP-1 Drugs Clinical Research Historical Pharmacology Drug Treatment Obesity Treatment Drugs Contraceptive Medication Efficacy Studies Pain Relief Acetaminophen Toxinology Drug Delivery Systems Alzheimer's Disease Treatment Neuropharmacology Antibiotic Resistance Therapeutics Contraceptive Effectiveness Reproductive Health

Can-Fite's Namodenoson Clears Phase IIa Safety Bar in Pancreatic Cancer

Efficacy results remain immature with survival follow-up ongoing.

Eupraxia Reports Early EoE Trial Data With Near‑Normal Tissue at Top Dose

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Cambridge Scientists Grow Self-Organising ‘Hematoids’ That Produce Human Blood Stem Cells

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use

OTC Birth Control Tied to Major Uptake Gains in First Year, National Study Finds

Etienne-Emile Baulieu, Inventor of RU-486, Dies at 98

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies